Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

NCT00106262 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Cervical Cancer

Interventions

DRUG: Velcade (bortezomib)
DRUG: Irinotecan

Sponsor

Women and Infants Hospital of Rhode Island

Collaborators

[object Object]